Health Canada announced January 1st, 2018 as the proposed date for mandatory filing of specified regulatory activities in eCTD format, such as: • new drug submissions (NDS) • supplements to a new drug submission (SNDS) • abbreviated new drug submissions (ANDS), and • supplements to an abbreviated new drug submission (SANDS). Exemptions from the mandatory eCTD format requirement will be considered on a case-by-case basis and should be requested by email.
[/membership][membership level=”0,4″][The content continues for paid members only.]
Login or Subscribe [/membership][membership level=”1,5,6,7,8,9,10,11,12″][membership]
